Daily Archives: April 21, 2010

Advisory Committee Transparency Update – FDA and EMEA

In the United States, new medicines are considered for approval by various consultant committees that the FDA  uses to help assess an application for approval.  In the European Union, human medicines are considered for approval by the European Medicines Agency … Continue reading

Posted in Uncategorized | Comments Off